Our study provides further insight into this critical signaling cascade leading from TGF-β through AKT to FOXO3a/BCL6/p53/ that maintains the survival of CML stem cells upon treatment with TKIs. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.